Lack of benefit for prophylactic drugs of tension-type headache in adults: A systematic review

Family Practice

Volumn 27, Issue 2, 2009, Pages 151-165

  Verhagen, Arianne P ^a   Damen, Léonie ^a   Berger, Marjolein Y ^a   Passchier, Jan ^a   Koes, Bart W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Family medicine; Meta analysis; Preventive medicine; Randomized controlled trial; Systematic review

Indexed keywords

ALPRAZOLAM; AMITRIPTYLINE; ANALGESIC AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE; BUSPIRONE; CITALOPRAM; CLONIDINE; FLUPENTIXOL; MUSCLE RELAXANT AGENT; NIFEDIPINE; PLACEBO; PROPRANOLOL; SEROTONIN AGONIST; TIAPRIDE; TIZANIDINE; VASODILATOR AGENT;

ADULT; AGED; ARTICLE; CHRONIC TENSION HEADACHE; CLINICAL TRIAL; DISEASE CONTROL; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PAIN ASSESSMENT; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIDEPRESSIVE AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TENSION-TYPE HEADACHE;

EID: 77950951371     PISSN: 02632136     EISSN: 14602229     Source Type: Journal    
DOI: 10.1093/fampra/cmp089     Document Type: Article

References (67)

1. Schwartz BS, Stewart WF, Simon D, Lipton RB. Epidemiology of tension-type headache. J Am Med Assoc 1998; 279: 381-3.
2. Lyngberg AC, Rasmussen BK, Jørgensen T, Jensen R. Has the prevalence of migraine and tension-type headache changed over a 12-year period? A Danish population survey. Eur J Epidemiol 2005; 20: 243-9.
3. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988; 8 (suppl 7): 1-96.
4. Headache Classification Committee of the International Headache Society. The international classification of headache disorders. Cephalalgia 2004; 24 (suppl 1): 1-152.
5. Speciali JG, Eckeli AL, Dach F. Tension-type headache. Expert Rev Neurother 2008; 8: 839-53.
6. Tomkins GE, Jackson JL, O'Malley PG, Balden E, Santoro JE. Treatment of chronic headache with antidepressants: a metaanalysis. Am J Med 2001; 111: 54-63.
7. Moja PL, Cusi C, Sterzi RR, Canepari C. Selective serotonin reuptake inhibitors (SSRIs) for preventing migraine and tensiontype headaches. Cochrane Database Syst Rev 2005; (issue 3): CD002919.
8. Fumal A, Schoenen J. Tension-type headache: current research and clinical management. Lancet Neurol 2008; 7 (1): 70-83.
9. Robinson KA, Dickerson K. Development of a highly sensitive search strategy for the retrieval of reports of controlled trials using PubMed. Int J Epidemiol 2002; 31: 150-3.
10. Ad Hoc Committee on the Classification of Headache of the National Institute of Neurological Diseases and Blindness. Classification of headache. JAMA 1962; 179: 717-8.
11. Verhagen AP, de Vet HCW, de Bie RA et al. The Delphi list: a criteria list for quality assessment of randomised clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235-41.
12. Verhagen AP, de Vet HCW, de Bie RA, Boers M, van den Brandt PA. The art of quality assessment of RCTs included in systematic reviews. J Clin Epidemiol 2001; 54: 651-4.
13. Van Tulder MW, Furlan A, Bombarbier C, Bouter L. Editorial Board of the Cochrane Collabaration Back Review Group. Updated method guidelines for systematic reviews in the cochrane collaboration back review group. Spine 2003; 28: 1290-9.
14. Ashina S, Bendtsen L, Jensen R. Analgesic effect of amitriptyline in chronic tension-type headache is not directly related to serotin reuptake inhibition. Pain 2004; 108: 108-14.
15. Bendtsen L, Jensen R, Olesen J. A non-selective (amitriptyline), but not a selective (citalopram), serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tensiontype headache. J Neurol Neurosurg Psychiatr 1996; 61: 285-90.
16. Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 2000; 20: 603-10.
17. Gobel H, Hamouz V, Hansen C et al. Amitriptylin in der Therapie des chronischen Kopfschmerzes vom Spannungstyp. Nervenarzt 1994; 65: 670-9.
18. Gobel H, Hamouz V, Hansen C et al. Chronic tension-type headache: amitriptyline reduces clinical headache-duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 1994; 59: 241-9.
19. Langemark M, Loldrup D, Bech P, Olesen J. Clomipramine and mianserin in the treatment of chronic tension headache. A double-blind, controlled study. Headache 1990; 30: 118-21.
20. Loldrup D, Langemark M, Hansen HJ, Olesen J, Bech P. Clomipramine and mianserin in chronic idiopathic pain syndrome. A placebo controlled study. Psychopharmacology 1989; 99: 1-7.
21. Pfaffenrath V, Diener HC, Isler H et al. Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi-centre controlled study. Cephalalgia 1994; 14: 149-55.
22. Pfaffenrath V, Diener HC, Isler H et al. Wirksamkeit und Vertraglichkeit von Amitriptylinoxid beim chronischen Spannungskopfschmerz-Eine Multizentrische Doppelblindstudie versus Amitriptylin versus Plazebo. Nervenarzt 1993; 64: 114-20.
23. Worz R, Lobisch M, Gessler M et al. Flupirtine versus placebo in chronic tension-type headache. Headache Q 1996; 7: 30-8.
24. Worz R, Lobisch M, Schwittmann B et al. Wirksamkeit von Flupirtin bei chronischem spannungskopfschmerz. Ergebnisse einer Doppelblindstudie versus Plazebo. Fortschr Med 1995; 113: 463-8.
25. Bendtsen L, Jensen R. Mirtazapine is effective in the prophylactic treatment of chronic tension-type headache. Neurology 2004; 62: 1706-11.
26. De Benedittis G, Massei R. Serotonin precursors in chronic primary headache. A double-blind cross-over study with L-5hydroxytryptophan vs. placebo. J Neurosurg Sci 1985; 29: 239-48.
27. Denaro A, Martucci N, Ruggieri S, Manna V, Agnoli A. Headache and noradrenergic involvement: the effects of alpha 2-stimulants and alpha 2-antagonists. Acta Psychiatr Scand Suppl 1985; 320: 20-5.
28. Fogelholm R, Murros K. Maprotiline in chronic tension headache: a double-blind cross-over study. Headache 1985; 25: 273-5.
29. Fogelholm R, Murros K. Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study. Headache 1992; 32: 509-13.
30. Haas DC, Sheehe PR. Dextroamphetamine pilot crossover trials and n of 1 trials in patients with chronic tension-type headache and migraine headache. Headache 2004; 44: 1029-37.
31. Hackett GI, Boddie HG, Harrison P. Chronic muscle contraction headache: the importance of depression and anxiety. J R Soc Med 1987; 80: 689-91.
32. Martucci N, Manna V, Porto C, Agnoli A. Migraine and the noradrenergic control of vasomotricity: a study with alpha-2 stimulant and alpha-2 blocker drugs. Headache 1985; 25: 95-100.
33. Mørland TJ, Storli OV, Mogstad TE. Doxepin in the prophylactic treatment of mixed 'vascular' and tension headache. Headache 1979; 19: 382-3.
34. Shukla R, Garg RK, Nag D, Ahuja RC. Nifedipine in migraine and tension headache: a randomised double blind crossover study. J Assoc Physicians India 1995; 43: 770-2.
35. Shukla R, Nag D, Ahuja RC. Alprazolam in chronic tension type headache. J Assoc Physicians India 1996; 44: 641-4.
36. Sjaastad O. So-called "tension headache"-the response to a 5-HT uptake inhibitor: femoxetine. Cephalalgia 1983; 3: 53-60.
37. Bendtsen L, Buchgreitz L, Ashina S, Jensen R. Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. Eur J Neurol 2007; 14: 187-93.
38. Boz C, Altunayoglu V, Velioglu S, Ozmenoglu M. Sertraline versus amitriptyline in the prophylactic therapy of non-depressed chronic tension-type headache patients. J Headache Pain 2003; 4: 72-8.
39. Boline PD, Kassak K, Bronfort G, Nelson C, Anderson AV. Spinal manipulation vs. amitriptyline for the treatment of chronic tension-type headaches: a randomized clinical trial. J Manipulative Physiol Ther 1995; 18: 148-54.
40. Carasso RL, Yehuda S, Streifler M. Clomipramine and amitriptyline in the treatment of severe pain. Int J Neurosci 1979; 9: 191-4.
41. Cerbo R, Cesarino F, Bisceglia A et al. Amitriptyline effectiveness and plasma levels following low dose treatment in tension-type headache patients. Cephalalgia 1991; 11 (suppl 11): 331-2.
42. Holroyd KA, Nash JM, Pingel JD, Cordingley GE, Jerome A. A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive-behavioral) therapies for chronic tension headaches. J Consult Clin Psychol 1991; 59: 387-93.
43. Holroyd KA, O'Donnell FJ, Stensland M et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA 2001; 285: 2208-15.
44. Langemark M, Olesen J. Sulpiride and paroxetine in the treatment of chronic tension-type headache. An explanatory doubleblind trial. Headache 1994; 34: 20-4.
45. Manna V, Bolino F, Di Cicco L. Chronic tension-type headache, mood depression and serotonin: therapeutic effects of fluvoxamine and mianserine. Headache 1994; 34: 44-9.
46. Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981; 21: 105-9.
47. Mitsikostas DD, Gatzonis S, Thomas A, Ilias A. Buspirone vs amitriptyline in the treatment of chronic tension-type headache. Acta Neurol Scand 1997; 96: 247-51.
48. Nappi G, Sandrini G, Granella F et al. A new 5-HT2 antagonist (ritanserin) in the treatment of chronic headache with depression. A double-blind study vs amitriptyline. Headache 1990; 30: 439-44.
49. Oguzhanoglu A, Sahiner T, Kurt T, Akalin O. Use of amitriptyline and fluoxetine in prophylaxis of migraine and tension-type headaches. Cephalalgia 1999; 19: 531-2.
50. Rampello L, Alvano A, Chiechio S et al. Evaluation of the prophylactic efficacy of amitriptyline and citolapram, alone or in combination, in patients with comorbidity of depression, migraine and tension-type headache. Neuropsychobiology 2004; 50: 322-8.
51. Ribeiro CA. L-5-Hydroxytryptophan in the prophylaxis of chronic tension-type headache: a double-blind, randomized, placebocontrolled study. For the Portuguese Head Society. Headache 2000; 40: 451-6.
52. Saper JR, Silberstein SD, Lake AE 3rd, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache 1994; 34: 497-502.
53. Singh NN, Misra S. Sertraline in chronic tension-type headache. J Assoc Physicians India 2002; 50: 873-8.
54. DeTommaso M, Shevel E, Pecoraro C et al. Intra-oral orthosis vs. amitriptyline in chronic tension-type headache: a clinical and laser evoked potentials study. Head Face Med 2006; 2: 15.
55. Walker Z, Walker RWH, Robertson MM, Stansfeld S. Antidepressant treatment of chronic tension-type headache: a comparison between fluoxetine and desipramine. Headache 1998; 38: 523-8.
56. Worz R, Scherhag R. Treatment of chronic tension headache with doxepin or amitriptyline: results of a double-blind study. Headache Q 1990; 1: 216-23.
57. Zissis NP, Harmoussi S, Vlaikidis N et al. A randomized, doubleblind, placebo-controlled study of venlafaxine XR in outpatients with tension-type headache. Cephalalgia 2007; 27: 315-24.
58. Murros K, Kataja M, Hedman C et al. Modified-release formulation of tizanidine in chronic tension-type headache. Headache 2000; 40: 633-7.
59. Paiva T, Nunes JS, Moreira A et al. Effects of frontalis EMG biofeedback and diazepam in the treatment of tension headache. Headache 1982; 22: 216-20.
60. Bram G. Clinical and double-blind tests with MH 532 (Gamaquil) in tension headache. Schweiz Rundschau Med Praxis 1962; 51: 648-9.
61. Bettucci D, Testa L, Calzoni S et al. Combination of tizanidine and amitriptyline in the prophylaxis of chronic tension-type headache: evaluation of efficacy and impact on quality of life. J Headache Pain 2006; 7: 34-6.
62. Garcia-Alvarez F, Cortes Blanco M, Cabrero Lahuerta C et al. Tension headache treatment in outpatients' neurologic clinic setting. Psychologie Medicale 1994; 26: 215-23.
63. . Philadelphia panel. Philadelpia panel evidence-based clinical practice guidelines on selected rehabilitation interventions for shoulder pain. Phys Ther 2001; 81: 1719-30.
64. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008; 7: 354-61.
65. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-4.
66. Ioannidis JPA. Effectiveness of antidepressants: an evidence myth constructed from a thousand randomised trials? Bio Med Central 2008; 3: 14.
67. Medvedeva LA, Gnezdilov AV, Zagorul'ko OI, Syrovegin AV, Samoilova NV. Efficacy of neuroprotectors in patients with tension headaches. Neurosci Behav Physiol 2007; 5: 523-6.